MAP3K11 and breast carcinoma: Further, overexpression, silencing or inhibition of MLK3 in breast cancer cells had no effect on levels of the related transcription factor c-FOS, reflecting specificity in MLK3 control of FRA-1 (Supplementary Figure 4).